Research on Malaria

 “Be the change that you wish to see in the world.”

— Mahatma Gandhi

Malaria remains a leading cause of illness and death in sub-Saharan Africa, disproportionately affecting children under five. Despite existing treatments and preventive measures, the disease continues to pose significant health challenges.

Innovative Approach: PC240m

PC240m is a resonance-based remedy developed to treat and prevent malaria, and has been used since 2002. Initial observations in Malawi indicated that patients treated with PC240m remained free from frequent malaria attacks for six months or longer. This finding suggested potential for both treatment and prevention.

Malaria continues to claim lives across sub-Saharan Africa, especially among young children. ARHF’s fieldwork shows that PC240m—a natural, resonance-based remedy—may help reduce infections, hospitalizations, and deaths when used preventively in communities. Early data from regions where it has been distributed show remarkable declines in malaria-related cases and mortality, suggesting a powerful potential for wider impact.

PC240m is helping reduce malaria cases and save lives in Africa—especially among children. With your support, even more communities can benefit.

Subsequent applications of PC240m across various regions have yielded promising results

Field Observations and Community Impact

Democratic Republic of Congo (2009)

At a school in South Kivu, 600 children received regular doses of PC240m. Within months, the school reported no new malaria cases. In a nearby community, a local dispensary’s distribution of PC240m led to a 95% reduction in malaria cases at the nearby Red Cross hospital.

Malawi (2012)

A nursery caring for 300 children, which previously experienced five malaria-related child deaths annually, reported zero deaths after administering PC240m to all children.

Kenya (2014)

In a community of 20,000, the introduction of PC240m corresponded with a cessation of malaria-related deaths over a six-month period. A local carpenter, previously making multiple coffins weekly, noted the absence of demand and transitioned to a new profession. [1]

Africa Malaria Prevention Project (AMPP)

Building on these outcomes, ARHF launched the Africa Malaria Prevention Project (AMPP) in 2013, aiming to provide accessible, side-effect-free malaria prevention. In Malawi, after offering AMPP to 27,000 individuals, schools observed reduced absenteeism, and local hospitals reported decreased malaria-related hospitalizations and deaths. [1]

Epidemiological Study: Bukavu, DR Congo (2018–2023)

A non-randomized outcome study was conducted in the Kadutu Commune, comprising 13 health areas (HAs). Here are results:

Malaria-Related Hospitalisations (see graph)

•⁠ ⁠HA 1–5 (AMPP 2019–2023): Malaria cases dropped by 36% in 2022 and 30% in 2023 vs. 2018.
•⁠ ⁠HA 6–10 (non-AMPP 2019–2022): Malaria cases rose by 17% in 2022 vs. 2018. After AMPP rollout in 2023, cases dropped by 37%.
•⁠ ⁠HA 11–13 (non-AMPP 2019–2023): Malaria cases rose by 33% in 2022 vs. 2018, then fell by 10% in 2023.

Malaria Cases per 1000 (all ages)

Malaria-Related Deaths (see graph)

•⁠ ⁠HA 1–5 (AMPP 2019–2023): Deaths fell by 72% in 2022 and 79% in 2023 vs. 2018.
•⁠ ⁠HA 6–10 (AMPP in 2023): Deaths increased by 12% in 2022 vs. 2018. After AMPP in 2023, deaths dropped by 30%.
•⁠ ⁠HA 11–13 (non-AMPP 2019–2023): Deaths unchanged in 2022, then decreased by 17% in 2023 vs. 2018.

Malaria Related Deaths per 10000 (all ages)

Conclusion: Data from multiple regions strongly suggest that PC240m may enhance immunity against malaria and significantly reduce hospitalizations and deaths. In 2022, with only 35% of the population in Health Areas 1–5 participating in AMPP, malaria cases dropped by 36%, and malaria-related deaths fell by 72%. These findings demonstrate the potential of PC240m on a wider scale, and further research is encouraged to expand on these promising results. [2]

ARHF – A Story of Hope & Love

References

  1. Van der Zee HE (2016). Africa Malaria Prevention Project. Homoeopathic Links 2016;29(2):137–146.
  2. Van der Zee HE, Alimasi DB, Balikwisha JN, Walach H (2025). Novel Immune Supportive Prevention of Malaria, Data Collection Research in the city of Bukavu (DR Congo). International Journal of Malaria and Tropical Diseases (IJMTD) Vol. 6(1):113-121